184 related articles for article (PubMed ID: 17562998)
1. Topical bevacizumab therapy for corneal neovascularization.
DeStafeno JJ; Kim T
Arch Ophthalmol; 2007 Jun; 125(6):834-6. PubMed ID: 17562998
[No Abstract] [Full Text] [Related]
2. The effect of topical bevacizumab as an adjunctive therapy for corneal neovascularization.
Asena L; Akova YA; Cetinkaya A; Kucukerdonmez C
Acta Ophthalmol; 2013 May; 91(3):e246-8. PubMed ID: 22998029
[No Abstract] [Full Text] [Related]
3. Bevacizumab for corneal neovascularization.
Jacobs DS; Lim M; Carrasquillo KG; Rosenthal P
Ophthalmology; 2009 Mar; 116(3):592-3; author reply 593-4. PubMed ID: 19264217
[No Abstract] [Full Text] [Related]
4. Bevacizumab for graft rejection.
Harooni H; Reddy V; Root T; Ambati B
Ophthalmology; 2007 Oct; 114(10):1950. PubMed ID: 17908597
[No Abstract] [Full Text] [Related]
5. Topical bevacizumab for corneal neovascularization after penetrating keratoplasty.
Saxena S; Kishore P; Pandey S; Khattri M; Kumar D
Eur J Ophthalmol; 2009; 19(5):870-2. PubMed ID: 19787612
[TBL] [Abstract][Full Text] [Related]
6. The effect of topical bevacizumab on corneal neovascularization.
Kim SW; Ha BJ; Kim EK; Tchah H; Kim TI
Ophthalmology; 2008 Jun; 115(6):e33-8. PubMed ID: 18439681
[TBL] [Abstract][Full Text] [Related]
7. Subconjunctival bevacizumab for corneal neovascularization in herpetic stromal keratitis.
Carrasco MA
Cornea; 2008 Jul; 27(6):743-5. PubMed ID: 18580272
[TBL] [Abstract][Full Text] [Related]
8. Combined use of superficial keratectomy and subconjunctival bevacizumab injection for corneal neovascularization.
Qian CX; Bahar I; Levinger E; Rootman D
Cornea; 2008 Oct; 27(9):1090-2. PubMed ID: 18812781
[TBL] [Abstract][Full Text] [Related]
9. Bevacizumab as a potent inhibitor of inflammatory corneal angiogenesis and lymphangiogenesis.
Bock F; Onderka J; Dietrich T; Bachmann B; Kruse FE; Paschke M; Zahn G; Cursiefen C
Invest Ophthalmol Vis Sci; 2007 Jun; 48(6):2545-52. PubMed ID: 17525183
[TBL] [Abstract][Full Text] [Related]
10. Subconjunctival bevacizumab for corneal neovascularization.
Doctor PP; Bhat PV; Foster CS
Cornea; 2008 Oct; 27(9):992-5. PubMed ID: 18812760
[TBL] [Abstract][Full Text] [Related]
11. Subconjunctival bevacizumab for vascularized rejected corneal grafts.
Awadein A
J Cataract Refract Surg; 2007 Nov; 33(11):1991-3. PubMed ID: 17964413
[TBL] [Abstract][Full Text] [Related]
12. Topical bevacizumab and ocular surface neovascularization in patients with stevens-johnson syndrome.
Uy HS; Chan PS; Ang RE
Cornea; 2008 Jan; 27(1):70-3. PubMed ID: 18245970
[TBL] [Abstract][Full Text] [Related]
13. High-dose topical bevacizumab for corneal neovascularization.
Waisbourd M; Levinger E; Varssano D; Moisseiev E; Zayit-Soudri S; Barak A; Loewenstein A; Barequet I
Pharmacology; 2013; 92(5-6):310-4. PubMed ID: 24335191
[TBL] [Abstract][Full Text] [Related]
14. The effect of subconjuctival combined treatment of bevacizumab and triamcinolone acetonide on corneal neovascularization in rabbits.
Kang S; Chung SK
Cornea; 2010 Feb; 29(2):192-6. PubMed ID: 20098156
[TBL] [Abstract][Full Text] [Related]
15. Are we getting closer to prevention and treatment of corneal neovascularization?
Chévez-Barrios P
Clin Exp Ophthalmol; 2007 Nov; 35(8):689-90. PubMed ID: 17997767
[No Abstract] [Full Text] [Related]
16. Subconjunctival bevacizumab for corneal neovascularization.
Erdurmus M; Totan Y
Graefes Arch Clin Exp Ophthalmol; 2007 Oct; 245(10):1577-9. PubMed ID: 17458556
[TBL] [Abstract][Full Text] [Related]
17. Subconjunctival bevacizumab injection for corneal neovascularization.
Bahar I; Kaiserman I; McAllum P; Rootman D; Slomovic A
Cornea; 2008 Feb; 27(2):142-7. PubMed ID: 18216566
[TBL] [Abstract][Full Text] [Related]
18. Angioregressive pretreatment of mature corneal blood vessels before keratoplasty: fine-needle vessel coagulation combined with anti-VEGFs.
Koenig Y; Bock F; Kruse FE; Stock K; Cursiefen C
Cornea; 2012 Aug; 31(8):887-92. PubMed ID: 22362005
[TBL] [Abstract][Full Text] [Related]
19. Safety, penetration and efficacy of topically applied bevacizumab: evaluation of eyedrops in corneal neovascularization after chemical burn.
Yoeruek E; Ziemssen F; Henke-Fahle S; Tatar O; Tura A; Grisanti S; Bartz-Schmidt KU; Szurman P;
Acta Ophthalmol; 2008 May; 86(3):322-8. PubMed ID: 17995975
[TBL] [Abstract][Full Text] [Related]
20. Subconjunctival injection of bevacizumab (avastin) on corneal neovascularization in different rabbit models of corneal angiogenesis.
Chen WL; Lin CT; Lin NT; Tu IH; Li JW; Chow LP; Liu KR; Hu FR
Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1659-65. PubMed ID: 18997093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]